Ranking and prioritization of environmental risks of pharmaceuticals in surface waters

Regulatory Toxicology and Pharmacology

Volumn 39, Issue 2, 2004, Pages 158-183

  Sanderson, Hans ^a   Johnson, David J ^a   Reitsma, Tamara ^a   Brain, Richard A ^a   Wilson, Christian J ^a   Solomon, Keith R ^a  

^a UNIVERSITY OF GUELPH   (Canada)

Author keywords

Analgesics anti inflammatory drugs and antipyretics; Anthelmintics; Antibacterials; Antidiabetics; Antidressants; Antiepileptics; Antifungals; Antigout; Antihistamines; Antimalarials; Antimigraine; Antimuscarinics; Antineoplastcs and immunosuppressants

Indexed keywords

ANALGESIC AGENT; ANTIBIOTIC AGENT; ANTIDEPRESSANT AGENT; ANTIFUNGAL AGENT; ANTIGOUT AGENT; ANTIHISTAMINIC AGENT; ANTIMALARIAL AGENT; ANTINEOPLASTIC AGENT; ANTIVIRUS AGENT; ANXIOLYTIC AGENT; CARDIOVASCULAR AGENT; CENTRAL STIMULANT AGENT; CORTICOSTEROID; DOPAMINE; GASTROINTESTINAL AGENT; HEMOSTATIC AGENT; HYPNOTIC SEDATIVE AGENT; LOCAL ANESTHETIC AGENT; NEUROLEPTIC AGENT; PARAFFIN; PESTICIDE; PROSTAGLANDIN; SEDATIVE AGENT; SEX HORMONE; SUNSCREEN; SURFACE WATER; SURFACTANT; THYROID HORMONE; UNINDEXED DRUG; VITAMIN;

ALGA; ARTICLE; CORRELATION ANALYSIS; DANGEROUS GOODS; DRUG MANUFACTURE; ECOTOXICITY; ENVIRONMENT; ENVIRONMENTAL HEALTH; ENVIRONMENTAL IMPACT; FISH; MICROBIAL IMMUNITY; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE STRUCTURE ACTIVITY RELATION; RISK;

ALGAE; ANIMALS; DAPHNIA; DRUG TOXICITY; EUROPEAN UNION; FISHES; FRESH WATER; HAZARDOUS SUBSTANCES; HAZARDOUS WASTE; INDUSTRIAL WASTE; PHARMACEUTICAL PREPARATIONS; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP; RISK ASSESSMENT; SEWAGE; TOXICITY TESTS; WATER POLLUTANTS, CHEMICAL; WATER SUPPLY;

ALGAE;

EID: 1642308567     PISSN: 02732300     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yrtph.2003.12.006     Document Type: Article

References (71)

1. Altenburger R., Nedza M., Schüürmann G. Mixture toxicity and its modeling by quantitative structure-activity relationships. Environ. Toxicol. Chem. 22:2003;1900-1915.
2. Ashton, D., Kennedy, J., Thomas, K., Hilton, M., 2003. Evaluating the environmental risks of pharmaceuticals. Poster at SETAC 13th annual meeting Hamburg
3. ASTM, 1216, 1993. In: Gorsuch, J.W., Dwyer, F.J., Ingersoll, C.G., LaPoint, T.W. (Eds.), Environmental Toxicology and Risk Assessment, vol. 2, pp. 521-619. Section on SAR/QSAR in the Office of Pollution Prevention and Toxics. ASTM STP 1216, American Society for Testing and Materials, PA, USA
4. Boxall A.B.A., Fogg L.A., Kay P., Blackwell P.A., Pemberton E.J., Croxford A. Prioritization of veterinary medicines in the UK environment. Toxicol. Lett. 142:2003;207-218.
5. Boxall A.B.A., Kolpin D., Halling-Sørensen B., Tolls J. Are veterinary medicines causing environmental risks? Environ. Sci. Technol. 37:2003;286-294A.
6. Bradbury S.P., Russom C.L., Ankley G.T., Schultz T.W., Walker J.D. Overview of data and conceptual approaches for deviation of Quantitative Structure-Activity Relationships for ecotoxicological effects of organic chemicals. Environ. Tox. Chem. 22:2003;1789-1798.
7. Canada, 2001. A Canadian perspective on the precautionary approach/principle, discussion document. http://www.pco-bcp.gc.ca/raoics-srdc/ docs/precaution/Discussion/discussion_e.htm
8. Calamari D., Zuccato E., Castiglioni S., Bagnati R., Fanelli R. Stregic survey of therapeutic drugs in the rivers Po and Lambro in northern Italia. Environ. Sci. Technol. 37:2003;1241-1248.
9. Calow P., Forbes V.E. Does ecotoxicology inform ecological risk assessment? Environ. Sci. Technol. 37:2003;147A-151A.
10. Carlsen, L., 2003. An Introduction to QSAR for Regulatory Applications. Nordisk Ministerå, Copenhagen, Denmark, in press
11. CDER, 1998. Guidance for industry. Environmental assessment of human drug and biologics applications. USFDA. www.fda.gov/cder/guidance/index.htm
12. Christensen F. Pharmaceuticals in the environment - A human risk? Regul. Toxicol. Pharmacol. 28:1998;212-221.
13. CLASSIC, 2002. In: Giddings, J.M. (Ed.), Community Level Aquatic System Studies - Interpretation Criteria. SETAC
14. Clark B., Henry J.G., Mackay D. Fugacity analysis and model of organic chemical fate in a sewage treatment plant. Environ. Sci. Technol. 29:1995;1488-1494.
15. Cleuvers M. Aquatic ecotoxicity of pharmaceuticals including the assessment of combination effects. Toxicol. Lett. 142:2003;185-194.
16. Cleuvers, M., 2004. Mixture toxicity of the anti-inflammatory drugs diclofenac, ibuprofen, naproxen, and acetylsalicylic acid. Ecotoxicol. Environ. Saf., in press
17. Cunningham, V.L., Constable, D.C., 2002. Preliminary GSK model for estimating POTW removals for pharmaceutical compounds. Poster P-421, SETAC 23rd Annual Meeting in North America, 16-20 November, Salt Lake City Utah, US
18. Daughton C.G., Ternes T.A. Special report. Pharmaceuticals and personal care products in the environment: agents of subtle change? Environ. Health Perspect. 107:1999;907-938.
19. Daughton C.G. Cradle-to-cradle stewardship of drugs for minimizing their environmental disposition while promoting human health. 1. Rationale for and avenues toward a green pharmacy. Environ. Health Perspect. 111:2003;757-774.
20. Danish Board of Technology, 1996. The non-assessed chemicals in EU. Report 1996/5
21. DK-EPA, 2001. Report on the advisory list for selfclassification of dangerous substances. Environmental Project No. 636. Danish Environmental Protection Agency
22. Doll R. Proof of causality. Perspect. Biol. Med. 45:2002;499-515.
23. EMEA, 2003. The European Agency for the Evaluation of Medicinal Products Pre-Authorization Evaluation of Medicines for Human Use. Committee for proprietary medicinal products, draft note for guidance on environmental risk assessment of medicinal products for human use. CPMP/SWP/4447/00 draft. www.emea.eu.int
24. Environmental Toxicology and Chemistry, 2003. In: Walker, J.D. (Ed.), Special Issue on QSAR, vol. 22, No. 8
25. Escher B.I., Hermans J.L.M. Modes of action in ecotoxicology: their role in body burdens, species sensitivity, QSARs and mixture effects. A critical review. Environ. Sci. Technol. 36:2002;4201-4216.
26. EU, 2000. Communication from the commission on the precautionary principle. COM (2000) 1. Brussels 2/2-2000. http://europa.eu.int/eur-lex/en/com/ cnc/2000/com2000_0001en01.pdf
27. EU, 2001a. CSTEE. Discussion paper on environmental risk assessment of medical products for human use (non-genetically modified organisms (non-GMO) containing). CPMPpaperRAssessHumPharm12062001/D(01). Brussels, Belgium
28. EU, 2001b. White paper. Strategy for a future chemicals policy, COM (2001) 88 Final. http://europa.eu.int/comm/environment/chemicals/0188_16en.pdf (accessed 08-08-03)
29. EU, 2001c. Communication from the commission on a community strategy against antimicrobial resistance. http://europa.eu.int/comm/health/ph/others/ antimicrob_resist/am_02_en.pdf (accessed 08-08-03)
30. EU, 2002. EU Food Law News (02-137) Commission press release (IP/02/1891), 16-12-02. Council backs prohibition of antibiotics as growth promoters: Byrne welcomes political agreement on feed additives. http://www.foodlaw.rdg.ac.uk/news/eu-02137.htm (accessed 08-08-03).
31. FDA, 1995. Centre for drug evaluation and research (CDER). Guidance for industry for the submission of an environmental assessment in human drug applications and supplements, Food and Drug Administration, 1995
32. Halling-Sørensen B., Nors-Nielsen S., Lansky P.F., Ingerslev F., Holten-Lützhøft H.C., Jørgensen S.E. Occurrence, fate and effects of pharmaceutical substances in the environment - a review. Chemosphere. 36:1998;357-393.
33. Heberer T. Occurrence, fate, and removal of pharmaceutical residues in the aquatic envionment: a review of recent research data. Toxicol. Lett. 131:2002;5-17.
34. Hirsch R., Ternes T., Haberer K., Kratz K.-L. Occurrence of antibiotics in the aquatic environment. Sci. Total Environ. 225:1999;109-118.
35. Hornbaker M.H., Cullen A. The precautionary principle in practice: applying the Ashford framework to technological risk. Hum. Ecol. Risk Assess. 9:2003;789-810.
36. Howard, P.H., 1998. User's guide for the SMILES CAS program. http://esc.syrres.com/interkow/docsmile.htm (0707-2003)
37. Jones O.A.H., Voulvoulis N., Lester J.N. Human pharmaceuticals in the aquatic environment - a review. Environ. Technol. 22:2001;1383-1394.
38. Jones O.A.H., Voulvoulis N., Lester J.N. Aquatic environmental assessment of the top 25 English prescription pharmaceuticals. Water Res. 36:2002;5013-5022.
39. Jørgensen S.E., Halling-Sørensen B. Editorial: drugs in the environment. Chemosphere. 40:2000;691-699.
40. Kaiser K.L.E., Dearden C.J., Klein W., Schultz T.W. A note of caution to users of ECOSAR. Water Qual. Res. J. Can. 34:1999;179-182.
41. Klopman G., Saiakhov R., Rosenkrantz H.S. Multiple computer-automated structure evaluation study of aquatic toxicity II. Fathead minnow. Environ. Toxicol. Chem. 19:2000;441-447.
42. Kolpin D.W., Furlong E.T., Meyer M.T., Thurman E.M., Zaugg S.D., Barber L.R., Buxton H.T. Pharmaceuticals, hormones, and other organic wastewater contaminants in U.S streams, 1999-2000: a national reconnaissance. Environ. Sci. Technol. 36:2002;1202-1211.
43. Kümmerer K. Drugs in the environment: emission of drugs, diagnostic aids and disinfectants into wastewater by hospitals in relation to other sources - a review. Chemosphere. 45:2001;957-969.
44. Lam, M.W., Young, C.J., Brain, R.A., Johnson, D.J., Hanson, M.A., Wilson, C.J., Richards, S.M., Solomon, K.R., Mabury, S.A., 2003. The aquatic persistence of eight pharmaceuticals in outdoor microcosms monitored by HPLC-UV and LC-MS-MS using electrospray ionization. Environ. Toxicol. Chem., in press
45. Martindale, 2002. In: Sweetman, S.C. (Ed.), Martindale, The Complete Drug Reference, 33rd ed. Pharmaceutical Press Chicago, USA, 2483 pp
46. Meyland W.M., Howard P.H. User's Guide for the ECOSAR & EPIWIN Class Programs. 1998;North Syracuse, New York, USA.
47. Meyland W.M., Howard P.H. User's guide for the EPIWIN suite. 1999;North Syracuse, New York, USA.
48. Montsford M.H.M.M., Kalf D.F., van Vlaardingen P.L.A., Linders J.B.J.H. The exposure assessment of veterinary medicinal products. Sci. Tot. Env. 225:1999;119-133.
49. Moore D.R.J., Breton R.L., MacDonald D.B. A comparison of model performance for six quantitative structure-activity relationship packages that predict acute toxicity to fish. Environ. Toxicol. Chem. 22:2003;1799-1809.
50. Nabholz, V.J., Clements, R.G., Zeeman, M.G., Osborn, K.C., Wedge, R., 1993. Validation of structure activity relationships used by the USEPA's office of pollution prevention and toxics for the environmental hazard assessment of industrial chemicals. In: Gorsuch, J.W., Dwyer, F.J., Ingersoll, C.G., LaPoint, T.W. (Eds.), Environmental Toxicology and Risk Assessment, vol. 2, ASTM, 1216. 1993. ASTM STP 1216, American Society for Testing and Materials, PA, USA, pp. 571-591
51. Nabholz, V.J., 2001. SAR validation study. Poster Presentation at Society of Toxicology annual meeting March 2001 in San Francisco, USA
52. Nawaz M.S., Erickson B.D., Khan A.A., Khan S.A., Pothuluri J.V., Rafii F., Sutherland J.B., Wagner R.D., Cerniglia C.E. Human health impact and regulatory issuses involving antimicrobial resistance in the food animal production environment. Reg. Res. Persp. 1:2001;10-16.
53. NSF, 2003. A 10-year outlook for the United States National Science Foundation: Complex environmental systems, synthesis for earth, life, and society in the 21st century. http://www.nsf.gov/geo/ere/ereweb/ acere_synthesis_rpt.cfm (accessed 08-08-03)
54. Rapport D.J. The health of ecology and the ecology of health. Hum. Ecol. Risk Assess. 8:2002;205-213.
55. Reddersen K., Heberer T., Dunnbier U. Identification and significance of phenazone drugs and their metabolites in ground- and drinking water. Chemosphere. 49:2002;539-544.
56. Ren S. Ecotoxicity prediction using mechanism- and non-mechanism-based QSARs: a preliminary study. Chemosphere. 53:2003;1053-1065.
57. Richardson M.L., Bowron J.M. The fate of pharmaceutical chemicals in the aquatic environment - a review. J. Pharm. Pharmacol. 37:1985;1-12.
58. Salvito D.T., Senna R.J., Federle T.W. A framework for prioritizing fragrance materials for aquatic risk assessment. Environ. Toxicol. Chem. 21:2002;1301-1308.
59. Sanderson H., Petersen P. Power analysis as a reflexive scientific tool for interpretation and implementation of the precautionary principle in the European Union. Environ. Sci. Pollut. Res. 9:2002;221-226.
60. Sanderson, H., 2002. Design, analysis and interpretation of higher tier risk assessment of chemicals in aquatic microcosms. Doctoral dissertation, University of Roskilde, Denmark. http://www.ruc.dk/teksam/phdinfo/hans (accessed 08-08-03)
61. Sanderson H., Johnson D., Wilson C., Brain R., Solomon K.R. Probabilistic hazard assessment of environmentally ccurring pharmaceuticals acute toxicity to fish, daphnids and algae by ECOSAR screening. Toxicol. Lett. 144:2003;383-395.
62. Sanderson, H., Dyer, S., Nabholz, V.J., 2004. QSAR's and extrapolation. In: Solomon, KR., Sibley, PL., Sanderson, H., Richards, SM., Dyer, S., Brock, TCM., van den Brink, P., Posthuma, L., de Zwart, D., Extrapolation practice for ecological effect characterization of chemicals (EXPECT), SETAC Press, In prep
63. Schmieder P.K., Ankley G., Mekenyan O., Walker J.D., Bradbury S. Quantitative structure-activity relation models for prediction of estrogen receptor binding affinity of structurally diverse chemicals. Environ. Toxicol. Chem. 22:2003;1844-1854.
64. Seiler J.P. Pharmacodynamic activity of drugs and ecotoxicology - can the two be connected? Toxicol. Lett. 131:2002;105-115.
65. Straub J.O. Environmental risk assessment for new human pharmaceuticals in the Euorpean Union according to the draft guideline/discussion paper of January 2001. Toxicol. Lett. 131:2002;137-143.
66. Stuer-Lauridsen, F., Hansen, L., Birkved, M., Kjølholt, J., Mikkelsen, S., 2002. Litteraturudredning vedrørende human medicin i miljøet. Miljøprojekt Nr. 661. Danish EPA
67. Tong W., Perkins R., Fang H., Hong H., Xie Q., Branham W., Sheehan D.M., Anson J.F. Development of quantitative structure-activity relations (QSARs) and their use for priority setting in the testing strategy of endocrine disruptors. Reg. Res. Perspect. 1:2002;1-16.
68. US Federal Register, 1999. Category for persistent, bioaccumulation and toxic new chemical substances, Environmental Protection Agency, vol. 64, No. 213, November 4, p. 60198.
69. Weigel L.M., Clewell D.B., Gill S.R., Clark N.C., McDougal L.K., Flanagan S.E., Kolonay J.F., Shetty J., Killgore G.E., Tenover F.C. Genetic analysis of a high-level Vancomycin-resistant isolate of Stphylococcus aureus. Science. 302:2003;1569-1571.
70. WHO, 1997. The medical impact of antimicrobial use in food animals. World Health Organization emerging and other communicable diseases, surveillance and control. Berlin, Germany
71. Zeeman M., Auer C.M., Clements R.G., Nabholz J.V., Boethling R.S. U.S. EPA regulatory perspectives on the use of QSAR for new and existing chemical evaluations. SAR QSAR Environ. Res. 3:1995;170-201.